InsiderClue
Insiders · Profile

Krognes Steve E.

Director at Guardant Health · Director at Denali Therapeutics. Filing since 30 Mar 2020. CIK 0001666236

GH Guardant Health, Inc. Director · 2 trades DNLI Denali Therapeutics Inc. Director · 24 trades
Company
Date
Role
Action
Shares
Amount
Of holding
GH Guardant Health, Inc.
16 Sep 2026
Director
Sold at will
6,674
$1.17M
45.8%
GH Guardant Health, Inc.
4 Jun 2026
Director
Sold at will
9,294
$1.23M
47.6%
DNLI Denali Therapeutics Inc.
7 Jan 2025
Director
Sold at will
3,339
$69.48K
11.5%
DNLI Denali Therapeutics Inc.
31 Dec 2024
Director
Sold on a plan
30,000
$607.50K
50.8%
DNLI Denali Therapeutics Inc.
30 Sep 2024
Director
Sold on a plan
30,000
$870.90K
50.8%
DNLI Denali Therapeutics Inc.
20 Aug 2024
Director
Sold at will
1,727
$41.09K
5.0%
DNLI Denali Therapeutics Inc.
1 Jul 2024
Director
Sold on a plan
30,000
$663.67K
46.6%
DNLI Denali Therapeutics Inc.
13 Jun 2024
Director
Sold on a plan
688
$14.99K
1.3%
DNLI Denali Therapeutics Inc.
1 Apr 2024
Director
Sold on a plan
92,500
$1.90M
66.1%
DNLI Denali Therapeutics Inc.
13 Feb 2024
Director
Sold at will
2,750
$47.55K
1.9%
DNLI Denali Therapeutics Inc.
5 Jan 2024
Director
Sold at will
3,208
$62.33K
2.2%
DNLI Denali Therapeutics Inc.
21 Aug 2023
Director
Sold at will
1,419
$32.07K
1.0%
DNLI Denali Therapeutics Inc.
13 Feb 2023
Director
Sold, plan not stated
2,119
$63.78K
1.5%
DNLI Denali Therapeutics Inc.
8 Feb 2023
Director
Sold, plan not stated
1,377
$42.52K
0.9%
DNLI Denali Therapeutics Inc.
5 Jan 2023
Director
Sold, plan not stated
2,970
$84.47K
2.0%
DNLI Denali Therapeutics Inc.
19 Aug 2022
Director
Sold, plan not stated
2,253
$74.84K
1.5%
DNLI Denali Therapeutics Inc.
11 Feb 2022
CFO and Treasurer
Sold, plan not stated
2,560
$88.81K
2.1%
DNLI Denali Therapeutics Inc.
9 Feb 2022
CFO and Treasurer
Sold, plan not stated
1,296
$48.07K
1.0%
DNLI Denali Therapeutics Inc.
5 Jan 2022
CFO and Treasurer
Sold, plan not stated
2,225
$99.57K
1.8%
DNLI Denali Therapeutics Inc.
19 Aug 2021
CFO and Treasurer
Sold, plan not stated
2,285
$113.26K
2.3%
DNLI Denali Therapeutics Inc.
15 Mar 2021
CFO and Treasurer
Sold, plan not stated
50,000
$3.09M
5.6%
DNLI Denali Therapeutics Inc.
16 Feb 2021
CFO and Treasurer
Sold, plan not stated
50,000
$3.25M
5.3%
DNLI Denali Therapeutics Inc.
11 Feb 2021
CFO and Treasurer
Sold, plan not stated
3,035
$213.48K
3.0%
DNLI Denali Therapeutics Inc.
9 Feb 2021
CFO and Treasurer
Sold, plan not stated
1,448
$108.13K
10.0%
DNLI Denali Therapeutics Inc.
15 Jan 2021
CFO and Treasurer
Sold, plan not stated
50,000
$3.57M
5.0%
DNLI Denali Therapeutics Inc.
30 Mar 2020
CFO and Treasurer
Sold, plan not stated
1,428
$27.82K
0.1%
26 decisions on file.